Adverse event risk signal mining of anti-disialoganglioside 2 monoclonal antibody based on US FDA Adverse Event Reporting System

Shao Miaomiao, Sun Ximu, Zhou Han, Li Ying, Sun Yixin, Yang Changqing, Wang iaoling, Zhao Wen

PDF(566 KB)
PDF(566 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (10) : 592-600. DOI: 10.3760/cma.j.cn114015-20231016-00737

Adverse event risk signal mining of anti-disialoganglioside 2 monoclonal antibody based on US FDA Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(10): 592-600 https://doi.org/10.3760/cma.j.cn114015-20231016-00737

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(566 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉